Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 07/28/14 | Current report filing |
|
6 | ||
| 06/06/14 | Notice of Effectiveness |
|
1 | ||
| 06/06/14 | Prospectus filed pursuant to Rule 424(b)(3) |
|
137 | ||
| 06/04/14 | Confidential treatment order |
|
1 | ||
| 06/04/14 | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
2 | ||
| 05/23/14 | General form of registration statement for all companies including face-amount certificate companies |
|
 |
192 | |
| 05/15/14 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 05/15/14 | Statement of changes in beneficial ownership of securities |
|
4 | ||
| 05/15/14 | Quarterly report pursuant to Section 13 or 15(d) |
|
|
108 | |
| 05/13/14 | Confidential treatment order |
|
1 |